PBMs on Trial: The Practical Implications of SCOTUS’s Rutledge v. PCMA Decision

Today's episode provides members with an update on the U.S. Supreme Court’s decision in Rutledge v. PCMA.  We cover what the Court’s ruling against PBMs means for pharmacy practice, and we talk with Rep. Buddy Carter about where PBM regulation goes from here. 

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.